NSE seeks clarification from Bal Pharma on March 2026 quarter results

Regulatory & Legal

BALPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.8%1-day move

₹87.00

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-2.8-5.0-9.0-10.1-7.9-10.3+0.5+0.6——

Up moveDown movePending

AI summary

The stock exchange has asked Bal Pharma to clarify details about its quarterly results for the period ending 31 March 2026, under SEBI listing rules. The company has not yet responded. Clarification requests are common and often relate to unusual numbers, accounting treatment, or disclosures that the exchange wants explained before accepting the filing.

Likely market impact

Routine regulatory query, not a penalty or action. Watch for the company's reply, which could affect short-term sentiment if concerns emerge.